“…The characterization of the NLSs and NESs of the ORF3 proteins ( Wang et al., 2004 ; Poon et al., 2005 ; Hough et al., 2015 ; Gu et al., 2016 ) has begun to shed light on the subcellular localization of ORF3 proteins, which contributes to their different apoptotic activities. Particularly for the CAV ORF3 protein, phosphorylation sites ( Rohn et al., 2002 ; Rohn et al., 2005 ; Lanz et al., 2012 ; Kucharski et al., 2016 ; Feng et al., 2020 ), such as Thr108, Thr107, Thr56, and Thr61, are considered to be of vital importance to its nuclear localization and apoptotic effect, whereas it has not yet been discovered in the ORF3 proteins of PCV and DuCV. On the other hand, the CAV ORF3 protein, in particular, has a tumor cell-specific nuclear targeting signal ( Danen-Van Oorschot et al., 2003 ; Kuusisto et al., 2008 ), which indicates tumor-selective toxicity induced upon its accumulation in the nuclei of transformed cells ( Danen-Van Oorschot et al., 1997 ; Poon et al., 2005 ; Helck et al., 2008 ; Zhao et al., 2013 ).…”